AbbVie Inc. sell NightTrain
Summary
This prediction ended on 11.02.21 with a price of €85.99. The SELL prediction by NightTrain shows the price for AbbVie Inc. slightly increased by 2.98% during the runtime of the prediction. Dividends of €1.08 are taken into consideration when calculating the performance. NightTrain has 50% into this predictionAbbVie (ABBV) is a multinational biopharmaceutical company based in North Chicago, Illinois. It was spun off as a separate entity from Abbott Laboratories in 2013 and is primarily focused on the development and commercialization of drugs for the treatment of conditions such as immunology, oncology, and neuroscience. Its key product is Humira, which is used to treat a range of autoimmune diseases, generating a significant portion of the company's revenue. The company also has a pipeline of promising products in various stages of development, making it a reputable player in the pharmaceutical industry.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
AbbVie Inc. | -0.182% | -0.182% | 29.068% | 73.525% |
iShares Core DAX® | 1.743% | 1.903% | 18.038% | 16.248% |
iShares Nasdaq 100 | -2.088% | -0.640% | 25.594% | 34.551% |
iShares Nikkei 225® | 1.306% | 4.161% | 16.556% | 10.486% |
iShares S&P 500 | -0.093% | 0.169% | 24.312% | 36.773% |
Comments by NightTrain for this prediction
In the thread AbbVie Inc. diskutieren
In the thread Trading AbbVie Inc.